Congress' Program
Total Page:16
File Type:pdf, Size:1020Kb
3mm 5mm “ PEOPLE DO NOT DECIDE TO BECOME EXTRAORDINARY. THEY DECIDE TO ACCOMPLISH EXTRAORDINARY THINGS” SIR EDMUND HILLARY FIRST PERSON TO CLIMB MOUNT EVEREST Τρόπος διάθεσης: Περιορισμένη ιατρική συνταγή από ειδικό ιατρό EN ISO 9001:2008 και παρακολούθηση κατά τη διάρκεια της αγωγής. No.: 01010148 Ενδεικτική τιμή Epclusa (Ex-factory): 17.856,86€ Υπεύθυνη ως εκπρόσωπος του ΚΑΚ για συλλογή ΑΕ: Βοηθήστε να γίνουν τα φάρμακα πιο ασφαλή και Gilead Sciences Ελλάς M. EΠE, Αναφέρετε Ριζούντος 2 & Θράκης, 167 77 Ελληνικό. ΟΛΕΣ τις ανεπιθύμητες ενέργειες για ΟΛΑ τα φάρμακα Τηλ.: 210 89 30 100, Fax: 210 96 18 260 Συμπληρώνοντας στην “ΚΙΤΡΙΝΗ ΚΑΡΤΑ” ΕPC/GR/17-02//1059 Για την πλήρη, επικαιροποιημένη Π.Χ.Π. αποταθείτε στην εταιρεία Βοηθήστε να γίνουν τα φάρμακα πιο ασφαλή και Αναφέρετε ΟΛΕΣ τις ανεπιθύμητες ενέργειες για GR/3DHCV/0415/0078 ΟΛΑ τα φάρμακα Συμπληρώνοντας την «ΚΙΤΡΙΝΗ ΚΑΡΤΑ» Η διαφήμιση είναι σύμφωνη με την ισχύουσα νομοθεσία - Υπουργική Απόφαση ∆ΥΓ3(α)ΓΠ 32221 - ΦΕΚ B’ 1049/29.4.2013 και τον κώδικα δεοντολογίας του ΣΦΕΕ. Πριν τη συνταγογράφηση συμβουλευθείτε την πλήρη Περίληψη Χαρακτηριστικών των Προϊόντων. Για περισσότερες πληροφορίες απευθυνθείτε στην εταιρεία: AbbVie ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Μαρίνου Αντύπα 41-45, Νέο Ηράκλειο, 14121, Τηλ.: 214 4165555 TABLE OF CONTENTS Welcome Message .................................................................................................. 7 Organization ........................................................................................................ 8-9 General Information ....................................................................................... 11-15 - Venue/Dates & Hours/ Official Language/ Webcasting/ Accreditation/ e-Abstract Book/ Social Events ................................................. 11-13 - Registration/ Receipts/ Name Badge ................................................................... 13-14 - Certificate of Attendance/ Exhibition/ Mobile Phones/ Liability and Insurance/ Contact .................................................................................. 15 Scientific Information ..................................................................................... 17-20 - Guidelines for Invited Faculty & Presenting Authors ..................................... 17-18 - Oral Presentations ....................................................................................................... 19-20 - e-Poster Viewing ................................................................................................................ 20 Scientific Programme ..................................................................................... 23-47 - Thursday, March 9, 2017 ........................................................................................... 23-28 - Friday, March 10, 2017 ............................................................................................... 29-39 - Saturday, March 11, 2017 ......................................................................................... 40-47 E-Posters .................................,....................................................................... 49-85 Index of Invited Faculty .................................................................................. 87-92 Index of Oral Presentations & e-Posters ..................................................... 94- 108 Sponsors/Acknowledgements .......................................................................... 109 9th International Congress of Internal Medicine, March 9-11, 2017, Athens, Greece 5 Amgen Cardiovascular Αντιμετωπίζοντας τις προκλήσεις της υπερχοληστερολαιμίας με την πείρα 35 ετών ηγετικής θέσης στα βιολογικά φάρμακα Η καρδιαγγειακή νόσος (ΚΑΝ) είναι η κύρια αιτία νοσηρότητας και θνησιμότητας στην Ευρώπη1 Υπάρχει συσχέτιση μεταξύ των επιπέδων LDL-C και του κινδύνου εμφάνισης καρδιαγγειακών επεισοδίων2 GRCY-GRC-P-145-0916-038112 GRCY-GRC-P-145-0916-038112 Πολλοί ασθενείς παραμένουν σε υψηλό καρδιαγγειακό κίνδυνο καθώς δε μπορούν να μειώσουν την LDL-C στα συνιστώμενα επίπεδα3 Η Amgen φέρνει λύσεις για τη μείωση του φορτίου της καρδιαγγειακής νόσου4 Μάθετε περισσότερα: www.amgencardiovascular.eu 1. European Cardiovascular Disease Statistics 2012 edition. 2. LaRosa JC, et al. N Engl J Med. 2005;352:1425-35. 3. Perk J, et al. Eur Heart J. 2012;33(13):1635-701. 4. http://www.amgencardiovascular.eu/. Accessed: 3rd October 2016 èđĊċāĔĕĈďĄĆĂďđĖďĕĄėÿĒĄčĄČđĄĔėĄĎāčĄČçďĄėĀĒĈĕĈ ôðê÷ĕČēĄďĈČċĞĊĕĈēĈďĀĒĆĈČĈēĆČĄôðçĕĄėÿĒĄčĄ ĔĖĎĊĒğďđďĕĄēĕĊď©ïîøöîòìïçöøçª $0*(1+HOODVêõê çďĄėĀĒĈĕĈ čÿċĈ ĞđĕĊ ĄďĈČċĞĊĕĊ ĈďĀĒĆĈČĄ ĔĞėĚďĄ Ĉ ĕđ ĈċďČčĝ ĔĞĔĕĊĄ ĄďĄėđĒÿē Ĕĕđ øāĄ çďĈČċĞĊĕĚď êďĈĒĆĈČğď ĕđĖ êċďČčđĞ ôĒĆĄďČĔđĞ úĄĒÿčĚď éĒĄąČÿēñĄĒđĞĔČ êôú øĊĎ)D[ĈĕĊĘĒāĔĊĕĊēïĂĕĒČďĊēïÿĒĕĄēćČĄċĀĔČĊ čĄČ ĔĕĊď ČĔĕđĔĈĎĂćĄ ĕđĖ êôú ZZZHRIJU ĆČĄ ĀďĕĖĊ ā ĊĎĈčĕĒđďČčā ĖđąđĎā ā øĊĎ)D[ ĈďĄĎĎĄčĕČčÿĔĕĊď$0*(1êĎĎÿēúĄĒĄčĈĖĕČčÿêõêøĊĎ (PDLOLQIR#DPJHQJUZZZDPJHQJU WELCOME MESSAGE Dear colleagues, On behalf of the Organizing Committee, it is a great pleasure to welcome you all to the 9th International Congress of Internal Medicine, taking place on 9-11 March, 2017 at Hilton Athens Hotel, Greece. The Congress is organized with the joint effort of the Institute of Internal Medicine and Hepatology and the Department of Medicine and Research Laboratory of Internal Medicine of the University of Thessaly Medical School, Larissa, Greece. We are also glad that the Congress is organized in cooperation with the Hellenic As- sociation for the Study of the Liver and the Hellenic Stroke Organization. It is also endorsed by the European Federation of Internal Medicine and the Foundation for the Development of Internal Medicine in Europe and is under the auspices of the University of Thessaly Medical School. This major annual event in Greece is attended nationally and internationally by up- wards of 600-700 attendees from all over Greece and other European countries and with the active participation of established international scientists and experts. The last years the organizing and scientific committees have been focusing on a sin- gle goal, hopefully to make this congress an important scientific event beyond the Greek borders, open to friendships and collaborations, that will gain worldwide warm acceptance and recognition for its scientific merit. The success of the past congresses shows us that we walk on the right path towards this goal, enhances our passion and willingness for continuing this educational undertaking. Up to 78 established international scientists and experts of great impact will participate as faculty members. The scientific program also includes the traditional form of the ab- stract based sessions and provides young-and not only-colleagues with a great oppor- tunity to present their work, research and clinical experience through oral presentations and e-posters covering various section fields of Internal Medicine. Therefore we would like to thank all of our colleagues for their active participation in the programme. We would also like to thank all our sponsors for their important support. We are confident that the Congress will represent for all participants an unforgettable personal and professional experience, and we are happy to welcome you in Athens. Best regards, The President of the Organizing Committee George N. Dalekos Professor of Medicine, President, Institute of Internal Medicine and Hepatology, President, Hellenic Association for the Study of the Liver, Vice President, Internal Medicine Society of Greece, Head, Department of Medicine and Research Laboratory of Internal Medicine, Medical School, University of Thessaly, Larissa, Greece 9th International Congress of Internal Medicine, March 9-11, 2017, Athens, Greece 7 ORGANIZATION Organizers: INSTITUTE OF INTERNAL MEDICINE & HEPATOLOGY, LARISSA, GREECE DEPARTMENT OF MEDICINE & RESEARCH LABORATORY OF INTERNAL MEDICINE, UNIVERSITY OF THESSALY MEDICAL SCHOOL, LARISSA, GREECE Director: Professor G.N. Dalekos ORGANIZING COMMITTEE (BOARD MEMBERS OF THE INSTITUTE OF INTERNAL MEDICINE & HEPATOLOGY): President: G.N. Dalekos Members: K. Krapis K.P. Makaritsis C. Mandros G. Ntaios SCIENTIFIC COMMITTEE & FACULTY MEMBERS M. Akova S. Georgiadou C. Marañón D. Samonakis A. Alexopoulou S. Georgopoulos H. Mattle M. Samson Q. Anstee E. Giannitsioti F. Menichetti D. Sereni I. Baskozos L. Guillevin D.L. Menucci P.P. Sfikakis M. Blank C. Hadjichristodoulou N. Montano K. Spengos S. Blot S.J. Hadziyannis P. Montravers A. Stefos Y. de Boer Α. Hatzitolios V. Mouchtouri D. Strbian E. Boutati G. Hirschfield H.Μ. Moutsopoulos H. Toplak M. Burnier T. Hofmann P. Nilsson Ε.V. Tsianos H.R. van Buuren G.K. Hovingh G. Ntaios E.A. Tsochatzis E. Cholongitas C. Jamin C.J. Packard S. Unal L. Christou J. Jordan R. Pálsson P. Valensi G.L. Daikos Ν.L. Katsilambros N. Papanas Κ. Vemmos G.N. Dalekos M. Kohrmann G. Papatheodoridis D. Vergani M. Deutch J. Koskinas V. Papavasileiou P.G. Vlachoyiannopoulos M. Dichgans V. Kotsis D. Papazoglou M. Voulgarelis G.D. Dimitriadis C. Labropoulou-Karatza A. Pares H. Wedemeyer G. Dimopoulos V. Lambadiari T.R. Pedersen C. Weimar Μ.Α. Dimopoulos R. Liberal G. Petrikkos C. Yurdaydin S. Dourakis G. Lip J. Putaala Κ. Zachou M. Ekstedt J.A. Lopes V. Ratziu A. Zanchetti Μ. Elisaf Κ.P. Makaritsis Y. Renaudineau D. Ziegler J.M. Ferro Ε. Maltezos Ε.I. Rigopoulou A. Floreani P.M. Mannucci Κ. Ritis Ν.K. Gatselis M.N. Manoussakis M. Rizzo 8 9th International Congress of Internal Medicine, March 9-11, 2017, Athens, Greece ORGANIZATION In cooperation with: HELLENIC ASSOCIATION FOR THE STUDY OF THE LIVER HELLENIC STROKE ORGANIZATION